The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro
Keywords: Cytomegalovirus; Heparan sulfate; Ganciclovir; Protease resistance; MCMV; HCMV; Peptide; CMV; cytomegalovirus; GCV; ganciclovir; HCMV; human cytomegalovirus; MCMV; murine cytomegalovirus; p.i.; post infection; pfu; plaque forming units; i.p.; intraperiton